Computer Programs and Systems, Inc. (CPSI)
(Delayed Data from NSDQ)
$26.84 USD
-3.21 (-10.68%)
Updated May 3, 2019 04:00 PM ET
After-Market: $26.84 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$26.84 USD
-3.21 (-10.68%)
Updated May 3, 2019 04:00 PM ET
After-Market: $26.84 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Computer Programs and Systems (CPSI) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Computer Programs and Systems (CPSI) delivered earnings and revenue surprises of 5.88% and 2.83%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Axonics Modulation Technologies (AXNX) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Axonics (AXNX) delivered earnings and revenue surprises of 116.67% and 0.37%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for November 27th
by Zacks Equity Research
ARLP, BCH and CPSI have been added to the Zacks Rank #5 (Strong Sell) List on November 27, 2023.
Computer Programs and Systems (CPSI) Q3 Earnings Beat Estimates
by Zacks Equity Research
Computer Programs and Systems (CPSI) delivered earnings and revenue surprises of 12.50% and 2.65%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Computer Programs and Systems (CPSI) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Computer Programs and Systems (CPSI) delivered earnings and revenue surprises of -33.33% and 1.61%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Health Catalyst (HCAT) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Health Catalyst (HCAT) delivered earnings and revenue surprises of 266.67% and 0.75%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
IRhythm Technologies (IRTC) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
iRhythm Technologies (IRTC) delivered earnings and revenue surprises of 18.67% and 3.41%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Outset Medical, Inc. (OM) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Outset Medical, Inc. (OM) delivered earnings and revenue surprises of 5.48% and 2.46%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Computer Programs and Systems (CPSI) Misses Q1 Earnings Estimates
by Zacks Equity Research
Computer Programs and Systems (CPSI) delivered earnings and revenue surprises of -23.68% and 2.05%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Computer Programs and Systems (CPSI) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Computer Programs and Systems (CPSI) delivered earnings and revenue surprises of 3.39% and 2.30%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Outset Medical, Inc. (OM) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Outset Medical, Inc. (OM) delivered earnings and revenue surprises of 6.58% and 1.57%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Computer Programs and Systems (CPSI) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
by Zacks Equity Research
Computer Programs and Systems (CPSI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Axonics (AXNX) Soars 10.6%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Axonics (AXNX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Computer Programs and Systems (CPSI) Q3 Earnings Lag Estimates
by Zacks Equity Research
Computer Programs and Systems (CPSI) delivered earnings and revenue surprises of -13.64% and 0.93%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Computer Programs and Systems (CPSI) Q2 Earnings Miss Estimates
by Zacks Equity Research
Computer Programs and Systems (CPSI) delivered earnings and revenue surprises of -13.24% and 5.82%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Nextgen Healthcare (NXGN) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Nextgen Healthcare (NXGN) delivered earnings and revenue surprises of 6.67% and 0.01%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
CPSI vs. OMCL: Which Stock Is the Better Value Option?
by Zacks Equity Research
CPSI vs. OMCL: Which Stock Is the Better Value Option?
Is Computer Programs and Systems (CPSI) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how Computer Programs and Systems (CPSI) and Evolus, Inc. (EOLS) have performed compared to their sector so far this year.
CPSI vs. CERN: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
CPSI vs. CERN: Which Stock Is the Better Value Option?
Has Evolus (EOLS) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Evolus, Inc. (EOLS) and Computer Programs and Systems (CPSI) have performed compared to their sector so far this year.
CPSI vs. OMCL: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
CPSI vs. OMCL: Which Stock Is the Better Value Option?
Has Computer Programs and Systems (CPSI) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Computer Programs and Systems (CPSI) and Meridian Bioscience (VIVO) have performed compared to their sector so far this year.
Computer Programs and Systems (CPSI) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Computer Programs and Systems (CPSI) delivered earnings and revenue surprises of 22.73% and 3.85%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Is Computer Programs and Systems (CPSI) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
What's in Store for Axcelis Technologies (ACLS) Q1 Earnings?
by Zacks Equity Research
Axcelis Technologies' (ACLS) earnings in first-quarter 2022 are likely to have benefited from strong growth of the Purion Power Series product line.